Korean drug price reform imminent

Published: 2010-02-03 07:00:00

Updated: 2010-02-03 07:00:00

A new wave of price cuts for drugs is speculated to be imminent in Korea, which has stirred up concerns among drug makers, multinational and domestic alike.

Rumors have spread that the Ministry of Health and Welfare Affairs is to implement reform on the pricing of drugs with potential price sl...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK